Please use this identifier to cite or link to this item:
Title: Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
Authors: Ang, P.W.
Loh, M. 
Liem, N.
Lim, P.L.
Grieu, F.
Vaithilingam, A.
Platell, C.
Yong, W.P. 
Iacopetta, B.
Soong, R. 
Issue Date: 21-May-2010
Citation: Ang, P.W., Loh, M., Liem, N., Lim, P.L., Grieu, F., Vaithilingam, A., Platell, C., Yong, W.P., Iacopetta, B., Soong, R. (2010-05-21). Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 10 : -. ScholarBank@NUS Repository.
Abstract: Background: Most previous studies of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC) have been conducted on a relatively small numbers of CpG sites. In the present study we performed comprehensive DNA methylation profiling of CRC with the aim of characterizing CIMP subgroups.Methods: DNA methylation at 1,505 CpG sites in 807 cancer-related genes was evaluated using the Illumina GoldenGate® methylation array in 28 normal colonic mucosa and 91 consecutive CRC samples. Methylation data was analyzed using unsupervised hierarchical clustering. CIMP subgroups were compared for various clinicopathological and molecular features including patient age, tumor site, microsatellite instability (MSI), methylation at a consensus panel of CpG islands and mutations in BRAF and KRAS.Results: A total of 202 CpG sites were differentially methylated between tumor and normal tissue. Unsupervised hierarchical clustering of methylation data from these sites revealed the existence of three CRC subgroups referred to as CIMP-low (CIMP-L, 21% of cases), CIMP-mid (CIMP-M, 14%) and CIMP-high (CIMP-H, 65%). In comparison to CIMP-L tumors, CIMP-H tumors were more often located in the proximal colon and showed more frequent mutation of KRAS and BRAF (P < 0.001).Conclusions: Comprehensive DNA methylation profiling identified three CRC subgroups with distinctive clinicopathological and molecular features. This study suggests that both KRAS and BRAF mutations are involved with the CIMP-H pathway of CRC rather than with distinct CIMP subgroups. © 2010 Ang et al; licensee BioMed Central Ltd.
Source Title: BMC Cancer
ISSN: 14712407
DOI: 10.1186/1471-2407-10-227
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2010-comprehensive_profiling_DNA_methylation_colorectal-published.pdf1.07 MBAdobe PDF




checked on Aug 12, 2022


checked on Aug 12, 2022

Page view(s)

checked on Aug 18, 2022


checked on Aug 18, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.